Found: 54
Select item for more details and to access through your institution.
CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 347, doi. 10.1016/j.clgc.2023.12.003
- By:
- Publication type:
- Article
Emerging Studies of Melanoma Brain Metastasis.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 5, p. 585, doi. 10.1007/s11912-022-01237-9
- By:
- Publication type:
- Article
Evolving Immunotherapy Approaches for Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 9, p. 1, doi. 10.1007/s11912-016-0542-9
- By:
- Publication type:
- Article
MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Immunotherapy utilization in stage IIIA melanoma: less may be more.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1336441
- By:
- Publication type:
- Article
Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumab.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1026964
- By:
- Publication type:
- Article
Drug targets and predictive biomarkers in the management of metastatic melanoma.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2012, v. 5, p. 139, doi. 10.2147/PGPM.S25100
- By:
- Publication type:
- Article
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
- Published in:
- Nature Genetics, 2015, v. 47, n. 9, p. 996, doi. 10.1038/ng.3361
- By:
- Publication type:
- Article
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
- Published in:
- Nature Genetics, 2012, v. 44, n. 9, p. 1006, doi. 10.1038/ng.2359
- By:
- Publication type:
- Article
MEK targeting in N-RAS mutated metastatic melanoma.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-45
- By:
- Publication type:
- Article
Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0069748
- By:
- Publication type:
- Article
Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031331
- By:
- Publication type:
- Article
Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01688-5
- By:
- Publication type:
- Article
Advances in the Systemic Treatment of Metastatic Melanoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 5, p. 1
- By:
- Publication type:
- Article
Ipilimumab: A Promising Immunotherapy for Melanoma.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1280
- By:
- Publication type:
- Article
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03773-8
- By:
- Publication type:
- Article
GP100 expression is variable in intensity in melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03776-5
- By:
- Publication type:
- Article
Anti-PD-1 Therapy-Associated Perforating Colitis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Agonistic CD40 Antibodies in Cancer Treatment.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1302, doi. 10.3390/cancers13061302
- By:
- Publication type:
- Article
Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1049, doi. 10.3390/cancers13051049
- By:
- Publication type:
- Article
Adverse Histopathologic Characteristics in Small Papillary Renal Cell Carcinomas Have Minimal Impact on Prognosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors.
- Published in:
- BMC Clinical Pathology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6890-13-3
- By:
- Publication type:
- Article
Characterizing disease states from topological properties of transcriptional regulatory networks.
- Published in:
- BMC Bioinformatics, 2006, v. 7, p. 236, doi. 10.1186/1471-2105-7-236
- By:
- Publication type:
- Article
Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery.
- Published in:
- Journal of Radiosurgery & SBRT, 2016, v. 4, n. 2, p. 97
- By:
- Publication type:
- Article
Vascular mimicry as a facilitator of melanoma brain metastasis.
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05217-z
- By:
- Publication type:
- Article
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 7, p. 1, doi. 10.1007/s00018-022-04364-5
- By:
- Publication type:
- Article
αB‐crystallin as a marker of lymph node involvement in breast carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 12, p. 2543
- By:
- Publication type:
- Article
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma.
- Published in:
- Cancer Cell International, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1475-2867-14-4
- By:
- Publication type:
- Article
Immunotherapy for metastatic melanoma.
- Published in:
- Journal of Cellular Biochemistry, 2012, v. 113, n. 3, p. 725, doi. 10.1002/jcb.23402
- By:
- Publication type:
- Article
Systemic immunotherapy for the Treatment of Brain Metast.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00049
- By:
- Publication type:
- Article
Rab33A: Characterization, Expression, and Suppression by Epigenetic Modification.
- Published in:
- Journal of Investigative Dermatology, 2006, v. 126, n. 10, p. 2257, doi. 10.1038/sj.jid.5700386
- By:
- Publication type:
- Article
Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vascularity of primary and metastatic renal cell carcinoma specimens.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-15
- By:
- Publication type:
- Article
Vascularity of primary and metastatic renal cell carcinoma specimens.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Incidence of the V600K mutation amongmelanoma patients with BRAF mutations, andpotential therapeutic response to the specificBRAF inhibitor PLX4032.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 67, doi. 10.1186/1479-5876-8-67
- By:
- Publication type:
- Article
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 6, doi. 10.1186/1479-5876-5-6
- By:
- Publication type:
- Article
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00330-3
- By:
- Publication type:
- Article
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase 2 trial of dasatinib in advanced melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 10, p. 2202, doi. 10.1002/cncr.25766
- By:
- Publication type:
- Article
Patterns of brain metastases response to immunotherapy with pembrolizumab.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 3, p. 555, doi. 10.1007/s11060-024-04754-8
- By:
- Publication type:
- Article
Patterns of brain metastases response to immunotherapy with pembrolizumab.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 2, p. 555, doi. 10.1007/s11060-024-04754-8
- By:
- Publication type:
- Article
Correction to: Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 154, n. 2, p. 197, doi. 10.1007/s11060-021-03813-8
- By:
- Publication type:
- Article
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.990367
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.836859
- By:
- Publication type:
- Article
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 51, doi. 10.1111/pcmr.13116
- By:
- Publication type:
- Article
Clinical trials in melanoma patients with brain metastases.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 6, p. 741, doi. 10.1111/pcmr.12401
- By:
- Publication type:
- Article
Radiation sensitivity and sensitization in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 6, p. 928, doi. 10.1111/pcmr.12147
- By:
- Publication type:
- Article
In vitro studies of dasatinib, its targets and predictors of sensitivity.
- Published in:
- Pigment Cell & Melanoma Research, 2011, v. 24, n. 2, p. 386, doi. 10.1111/j.1755-148X.2011.00835.x
- By:
- Publication type:
- Article